img

Global Human DNA Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Human DNA Vaccines Market Research Report 2024

DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially.
According to MRAResearch’s new survey, global Human DNA Vaccines market is projected to reach US$ 5250.7 million in 2033, increasing from US$ 4549.2 million in 2022, with the CAGR of 2.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human DNA Vaccines market research.
Key companies engaged in the Human DNA Vaccines industry include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Human DNA Vaccines were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human DNA Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Human DNA Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine

Segment by Application


Influenza
Human Papillomavirus
HIV
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human DNA Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human DNA Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market by Application
1.3.1 Global Human DNA Vaccines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Influenza
1.3.3 Human Papillomavirus
1.3.4 HIV
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human DNA Vaccines Market Perspective (2018-2033)
2.2 Human DNA Vaccines Growth Trends by Region
2.2.1 Global Human DNA Vaccines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Human DNA Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Human DNA Vaccines Forecasted Market Size by Region (2024-2033)
2.3 Human DNA Vaccines Market Dynamics
2.3.1 Human DNA Vaccines Industry Trends
2.3.2 Human DNA Vaccines Market Drivers
2.3.3 Human DNA Vaccines Market Challenges
2.3.4 Human DNA Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human DNA Vaccines Players by Revenue
3.1.1 Global Top Human DNA Vaccines Players by Revenue (2018-2023)
3.1.2 Global Human DNA Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Human DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human DNA Vaccines Revenue
3.4 Global Human DNA Vaccines Market Concentration Ratio
3.4.1 Global Human DNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human DNA Vaccines Revenue in 2022
3.5 Human DNA Vaccines Key Players Head office and Area Served
3.6 Key Players Human DNA Vaccines Product Solution and Service
3.7 Date of Enter into Human DNA Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human DNA Vaccines Breakdown Data by Type
4.1 Global Human DNA Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Human DNA Vaccines Forecasted Market Size by Type (2024-2033)
5 Human DNA Vaccines Breakdown Data by Application
5.1 Global Human DNA Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Human DNA Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Human DNA Vaccines Market Size (2018-2033)
6.2 North America Human DNA Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Human DNA Vaccines Market Size by Country (2018-2023)
6.4 North America Human DNA Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human DNA Vaccines Market Size (2018-2033)
7.2 Europe Human DNA Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Human DNA Vaccines Market Size by Country (2018-2023)
7.4 Europe Human DNA Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human DNA Vaccines Market Size (2018-2033)
8.2 Asia-Pacific Human DNA Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Human DNA Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific Human DNA Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human DNA Vaccines Market Size (2018-2033)
9.2 Latin America Human DNA Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Human DNA Vaccines Market Size by Country (2018-2023)
9.4 Latin America Human DNA Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human DNA Vaccines Market Size (2018-2033)
10.2 Middle East & Africa Human DNA Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Human DNA Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa Human DNA Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Human DNA Vaccines Introduction
11.1.4 Merck Revenue in Human DNA Vaccines Business (2018-2023)
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Human DNA Vaccines Introduction
11.2.4 GSK Revenue in Human DNA Vaccines Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Human DNA Vaccines Introduction
11.3.4 Sanofi Revenue in Human DNA Vaccines Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 Zoties
11.4.1 Zoties Company Detail
11.4.2 Zoties Business Overview
11.4.3 Zoties Human DNA Vaccines Introduction
11.4.4 Zoties Revenue in Human DNA Vaccines Business (2018-2023)
11.4.5 Zoties Recent Development
11.5 Elanco
11.5.1 Elanco Company Detail
11.5.2 Elanco Business Overview
11.5.3 Elanco Human DNA Vaccines Introduction
11.5.4 Elanco Revenue in Human DNA Vaccines Business (2018-2023)
11.5.5 Elanco Recent Development
11.6 Boehringer-Ingelheim
11.6.1 Boehringer-Ingelheim Company Detail
11.6.2 Boehringer-Ingelheim Business Overview
11.6.3 Boehringer-Ingelheim Human DNA Vaccines Introduction
11.6.4 Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2018-2023)
11.6.5 Boehringer-Ingelheim Recent Development
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Detail
11.7.2 Indian Immunologicals Business Overview
11.7.3 Indian Immunologicals Human DNA Vaccines Introduction
11.7.4 Indian Immunologicals Revenue in Human DNA Vaccines Business (2018-2023)
11.7.5 Indian Immunologicals Recent Development
11.8 Plumbline Life Sciences
11.8.1 Plumbline Life Sciences Company Detail
11.8.2 Plumbline Life Sciences Business Overview
11.8.3 Plumbline Life Sciences Human DNA Vaccines Introduction
11.8.4 Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2018-2023)
11.8.5 Plumbline Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human DNA Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Recombinant Protein Vaccine
Table 3. Key Players of Gene-Based Vaccine
Table 4. Global Human DNA Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Human DNA Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Human DNA Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Human DNA Vaccines Market Share by Region (2018-2023)
Table 8. Global Human DNA Vaccines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Human DNA Vaccines Market Share by Region (2024-2033)
Table 10. Human DNA Vaccines Market Trends
Table 11. Human DNA Vaccines Market Drivers
Table 12. Human DNA Vaccines Market Challenges
Table 13. Human DNA Vaccines Market Restraints
Table 14. Global Human DNA Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Human DNA Vaccines Market Share by Players (2018-2023)
Table 16. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2022)
Table 17. Ranking of Global Top Human DNA Vaccines Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Human DNA Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human DNA Vaccines Product Solution and Service
Table 21. Date of Enter into Human DNA Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human DNA Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Human DNA Vaccines Revenue Market Share by Type (2018-2023)
Table 25. Global Human DNA Vaccines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Human DNA Vaccines Revenue Market Share by Type (2024-2033)
Table 27. Global Human DNA Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Human DNA Vaccines Revenue Market Share by Application (2018-2023)
Table 29. Global Human DNA Vaccines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Human DNA Vaccines Revenue Market Share by Application (2024-2033)
Table 31. North America Human DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Human DNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Human DNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Human DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Human DNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Human DNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Human DNA Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Human DNA Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Human DNA Vaccines Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Human DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Human DNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Human DNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Human DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Human DNA Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Human DNA Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Human DNA Vaccines Product
Table 49. Merck Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 50. Merck Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Human DNA Vaccines Product
Table 54. GSK Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Human DNA Vaccines Product
Table 59. Sanofi Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Zoties Company Detail
Table 62. Zoties Business Overview
Table 63. Zoties Human DNA Vaccines Product
Table 64. Zoties Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 65. Zoties Recent Development
Table 66. Elanco Company Detail
Table 67. Elanco Business Overview
Table 68. Elanco Human DNA Vaccines Product
Table 69. Elanco Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 70. Elanco Recent Development
Table 71. Boehringer-Ingelheim Company Detail
Table 72. Boehringer-Ingelheim Business Overview
Table 73. Boehringer-Ingelheim Human DNA Vaccines Product
Table 74. Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 75. Boehringer-Ingelheim Recent Development
Table 76. Indian Immunologicals Company Detail
Table 77. Indian Immunologicals Business Overview
Table 78. Indian Immunologicals Human DNA Vaccines Product
Table 79. Indian Immunologicals Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 80. Indian Immunologicals Recent Development
Table 81. Plumbline Life Sciences Company Detail
Table 82. Plumbline Life Sciences Business Overview
Table 83. Plumbline Life Sciences Human DNA Vaccines Product
Table 84. Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2018-2023) & (US$ Million)
Table 85. Plumbline Life Sciences Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human DNA Vaccines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Human DNA Vaccines Market Share by Type: 2022 VS 2033
Figure 3. Recombinant Protein Vaccine Features
Figure 4. Gene-Based Vaccine Features
Figure 5. Global Human DNA Vaccines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Human DNA Vaccines Market Share by Application: 2022 VS 2033
Figure 7. Influenza Case Studies
Figure 8. Human Papillomavirus Case Studies
Figure 9. HIV Case Studies
Figure 10. Human DNA Vaccines Report Years Considered
Figure 11. Global Human DNA Vaccines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Human DNA Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Human DNA Vaccines Market Share by Region: 2022 VS 2033
Figure 14. Global Human DNA Vaccines Market Share by Players in 2022
Figure 15. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Human DNA Vaccines Revenue in 2022
Figure 17. North America Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Human DNA Vaccines Market Share by Country (2018-2033)
Figure 19. United States Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Human DNA Vaccines Market Share by Country (2018-2033)
Figure 23. Germany Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Human DNA Vaccines Market Share by Region (2018-2033)
Figure 31. China Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Human DNA Vaccines Market Share by Country (2018-2033)
Figure 39. Mexico Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Human DNA Vaccines Market Share by Country (2018-2033)
Figure 43. Turkey Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Human DNA Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 46. GSK Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 48. Zoties Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 49. Elanco Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 50. Boehringer-Ingelheim Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 51. Indian Immunologicals Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 52. Plumbline Life Sciences Revenue Growth Rate in Human DNA Vaccines Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries